43 Review Article Recent developments in the role of reactive oxygen species in allergic asthma Jingjing Qu1,2*, Yuanyuan Li1*, Wen Zhong1, Peisong Gao2, Chengping Hu1 1Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China; 2Division of Allergy and Clinical Immunology, Johns Hopkins School of Medicine, Baltimore, MD, USA Contributions: (I) Conception and design: J Qu, Y Li, P Gao, C Hu; (II) Administrative support: None; (III) Provision of study materials or patients: None; (IV) Collection and assembly of data: None; (V) Data analysis and interpretation: W Zhong; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. *These authors contributed equally to this work. Correspondence to: Chengping Hu. Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China. Email:
[email protected]; Peisong Gao, MD, PhD. The Johns Hopkins Asthma & Allergy Center, 5501 Hopkins Bayview Circle, Room 3B.71, Baltimore, MD 21224, USA. Email:
[email protected]. Abstract: Allergic asthma has a global prevalence, morbidity, and mortality. Many environmental factors, such as pollutants and allergens, are highly relevant to allergic asthma. The most important pathological symptom of allergic asthma is airway inflammation. Accordingly, the unique role of reactive oxygen species (ROS) had been identified as a main reason for this respiratory inflammation. Many studies have shown that inhalation of different allergens can promote ROS generation. Recent studies have demonstrated that several pro-inflammatory mediators are responsible for the development of allergic asthma. Among these mediators, endogenous or exogenous ROS are responsible for the airway inflammation of allergic asthma. Furthermore, several inflammatory cells induce ROS and allergic asthma development.